← Open Payments lookup

DORINE OWALLA: Open Payments

NPI 1780277269 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,779 in 117 payments from 16 companies in 2025. Trend: 2023 $2,356 · 2024 $1,945 · 2025 $2,779

Food & beverage: $2,779
CompanyPaymentsAmount
ABBVIE INC.37$644
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$505
Janssen Pharmaceuticals, Inc15$462
Otsuka America Pharmaceutical, Inc.12$344
Alkermes, Inc.8$191
E.R. Squibb & Sons, L.L.C.3$156
Supernus Pharmaceuticals, Inc.1$125
Lundbeck LLC5$97
Axsome Therapeutics, Inc.4$91
Vanda Pharmaceuticals Inc.2$49

Products named: VRAYLAR, CAPLYTA, REXULTI, INVEGA SUSTENNA, ARISTADA, COBENFY, Qelbree, Auvelity.

Industry payments across TX — which companies pay providers there.